No attachments available.
National Gene Vector Biorepository and Coordinating Center(NGVB)
Contact and place of performance
Rashida S. Ferebee
Not specified
The work is focused in the following four main areas: 1.) Reagent Repository, 2.) Pharmacology and Toxicology Resources, 3.) Clinical trial and pharmacology study specimen archiving under Good Laboratory Practices (GLP) conditions, and 4.) Research and Development of qualified assays for Insertional Site Analysis.
The National Institutes of Health (NIH) issued award notice HHSN26818HV00004R for the National Gene Vector Biorepository and Coordinating Center (NGVB) on December 21, 2018. This requirement falls under NAICS 541713, Research and Development in Nanotechnology, and PSC code A. Rashida S. Ferebee is the designated point of contact for this award, which was published without additional attachments.
The scope of work encompasses four primary functional areas focused on gene vector resources and coordination. The contractor provides a reagent repository, pharmacology and toxicology resources, and specimen archiving for clinical trials and pharmacology studies under Good Laboratory Practices (GLP) conditions. Additionally, the mandate includes the research and development of qualified assays for Insertional Site Analysis.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.